@article{article, title  = {{MP70-10 FURTHER CHARACTERIZATION OF THE EFFECTS OF PRIOR OR NO PRIOR DOCETAXEL THERAPY ON CRPC PATIENTS WITH BONE METASTASES RECEIVING RA-223 IN THE PHASE 3 ALSYMPCA TRIAL}},

 publisher = {{Ovid Technologies (Wolters Kluwer Health)}},

 url = {{}},

 year = {{2014}},

 month = {{4}},

 author = {{Shore N and Sartor O and Vogelzang N and Hoskin P and Nilsson S and Coleman R and Parker C and Wahba M and Staudacher K}},

 doi = {{10.1016/j.juro.2014.02.2209}},

 volume = {{191}},

 journal = {{Journal of Urology}},

 issue = {{4S}},

 note = {{Accessed on 2025/10/10}}}